A national temporary ban on new Medicare enrollment could have long-term impacts on hospice affiliations among nonprofit providers. Fraudsters have bilked billions of Medicare dollars posing as new legitimate providers. The program integrity issues moved the moratoria forward and caused a trickle effect on mergers, acquisitions, affiliations and organic growth in the hospice space. This […]
Hospice merger and acquisition volume has regained momentum and is rapidly approaching pre-pandemic levels. For hospice, 48 deals took place in 2019, according to the M&A advisory firm The Braff Group. This was followed by the record-breaking years of 2020 through 2022, in which nearly 70 hospice transactions completed annually. Then hospice M&A entered a lull. […]
Regulatory scrutiny is slowing down hospice M&A deals in 2026, and the recently approved 2027 final rule will be no help. Interest in hospice acquisitions remains high, particularly among publicly traded companies and private equity firms. However, buyers are painstakingly combing through any potential compliance or billing issues during the diligence process, which is delaying […]
The acquisition of the home health and hospice provider Amedisys by the insurance mammoth UnitedHealth Group (NYSE: UNH) has far-reaching implications for the hospice community. The UnitedHealth Group subsidiary Optum in June 2023 inked its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. After leaping a series […]
Consolidation among nonprofit hospices has ramped up in recent years. The trend is not anticipated to abate any time soon amid rising costs and regulatory oversight. This is according to Mark Kulik, senior managing director at the Pennsylvania-based merger and acquisition advisory firm The Braff Group. Hospice consolidation activity has increased over the past few […]
Tariffs being implemented by the Trump administration could have a dampening effect on an already slumping hospice mergers and acquisitions market. Economic uncertainty has swirling around these trade policies. Tariffs tend to raise prices and often trigger interest rate increases by the Federal Reserve. This makes financing debt more expensive, and many buyers in the […]
In this episode of Hospice News Elevate, senior editor Jim Parker speaks with Mark Kulik, senior managing director for The Braff Group, about consolidation occurring in the nonprofit hospice space. A rising number of nonprofits are affiliating with one another or selling to for-profit companies. This episode discusses the leading trends. Tune in now!
Trends in hospice merger and acquisition (M&A) activity thus far in 2025 are diverting from industry expectations in varied ways as multi-pronged headwinds impact decision-making processes. The types of hospice transactions that have unfolded halfway through the year hold revealing signs of where the industry is headed on the horizon, according to Joe Widmar, director […]
Predictions of a hospice M&A rebound have fizzled as a volatile regulatory and economic climate threatens to curb transaction activity in 2025 and beyond. Among the recent changes impacting strategic hospice decisions is the unfurling of the Trump administration’s new reciprocal tariff policy, according to Mark Kulik, senior managing director at The Braff Group. The […]
Hospices that have palliative care service lines may be better poised for growth in the merger and acquisition landscape compared to others. But the ability to demonstrate sustainability and scalability of these services will be crucial to manifesting a return on investment. Investors’ interest in palliative care has slowly mounted in recent years, with these […]
